10 High Growth European Stocks To Buy

Page 8 of 10

3. Argenx SE (NASDAQ:ARGX)

5-Year Revenue Growth Rate: 94.72%

Number of Hedge Fund Holders: 50

Argenx SE (NASDAQ:ARGX) ranks among the best high growth European stocks to buy. On January 12, William Blair maintained its Outperform rating on Argenx SE (NASDAQ:ARGX), citing robust sales growth in the company’s Vyvgart brand. The firm reports that Vyvgart sales stay ahead of expectations and demonstrate solid momentum, which it expects to last through 2026 across authorized applications in MG (myasthenia gravis) and CIDP.

The firm also emphasized the potential of Argenx’s other clinical products, including empasiprubart in MMN (multifocal motor neuropathy), which the firm sees as having massive potential, with pivotal EMPASSION data coming in the fourth quarter of 2026.

Moreover, the FDA recently agreed to give priority review to a supplemental biologics licensing application for Vyvgart. The application aims to increase Vyvgart’s usage in treating adults with acetylcholine receptor antibody-seronegative generalized myasthenia gravis (gMG), increasing the patient group eligible for the drug.

Argenx SE (NASDAQ:ARGX) is a biotech company that develops treatments for severe autoimmune diseases. The company operates through four segments: the United States, Japan, EMEA, and China.

Page 8 of 10